All Government articles – Page 89
-
NewsBritish Antarctic Survey merger binned
Cost saving plans are scrapped after outcry by politicians and scientists
-
NewsBattle over US environment agency's human studies
EPA accused of supporting clinical trials that expose study subjects to airborne particles at unsafe levels
-
News
Funding worries in UK higher education
Think tank calculates that UK tuition fees reform might not save any money at all
-
Business
Problems for Russian chemicals?
Accession to WTO will force government to ditch badly needed subsidies
-
NewsEPSRC grant success rates rise
Approval rates rise to their highest level in a decade but hide a worrying fall in the number of applications
-
News
Attempts to reform Croatian science stall
Controversy over changes to promotions and retirement age send the reforms back to the drawing board
-
News
Government adds £200 million to research partnership fund
Cash boost to fund designed to improve university-industry collaboration
-
NewsIllegal medicines seized in worldwide operation
Largest crackdown on illegal internet pharmacies ever nets £6.5 million of fake and unlicensed drugs
-
News
EU food agency criticises GM maize cancer paper
A review of a paper linking herbicide tolerant maize to tumours in rats has been castigated as poor science
-
News
US public research universities in jeopardy, board warns
Diminishing state funding threatens public universities’ ability to train the next generation of scientists and engineers
-
BusinessMeasuring nano the European way
Report concludes that companies will need lots of methods to define nanomaterials
-
NewsLiberal Democrats pledge support for UK science
Party pass science policy paper unanimously at its conference in Brighton
-
News
£10 million open access boost
UK funding council’s stance on open access to be supported with an extra £10 million investment from government
-
NewsRebuilding public trust in Japanese science
Public faith in the role of science-based decision-making faltered after the tsunami and Fukushima and won’t be easy recover
-
NewsPresidential candidates search for the right chemistry
In the quest for the US presidency, Obama has greater credibility with science groups, Romney has more industry support
-
Business
Alzheimer's drug flops in Phase III
Solanezumab from Eli Lilly missed the cognitive and functional primary endpoints of the trials
-
Business
Generic Actos approved
Mylan, Ranbaxy and Teva have won US marketing approval for their generic versions of Actos diabetes tablets
-
Business
Bapineuzunab dropped
Development for the Alzheimer’s treatment stopped after clinical tests
-
Business
New cystic fibrosis drug in EU
Ivacaftor works by helping defective proteins function more normally